The challenges of developing and commercializing biosimilars in Latin America
Pharm Pat Anal
.
2019 Nov;8(6):221-224.
doi: 10.4155/ppa-2019-0026.
Epub 2020 Jan 3.
Authors
Rodrigo González-Ramírez
1
,
Gilberto Castañeda-Hernández
2
Affiliations
1
Independent Consultant, Mexico City, Mexico.
2
Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, 07360 Mexico City, Mexico.
PMID:
31898930
DOI:
10.4155/ppa-2019-0026
No abstract available
Keywords:
Latin America; biosimilars; intended copies.
Publication types
Editorial
MeSH terms
Biosimilar Pharmaceuticals*
Drug Development*
Drug Industry
Latin America
Rituximab
Substances
Biosimilar Pharmaceuticals
Rituximab